The nanoparticles demonstrated targeted delivery to murine lung TAMs and delivery of siRNA to those cells and to lung cancer cells. Due to the hybrid approach (silencing the VEGF gene), this system showed significant efficacy in inhibiting tumor progression. This evidence concerns the gene VEGFA and lung cancer.